SE463100B - 1,3-oxazolidin-2-on-derivat och foerfaranden foer framstaellning daerav - Google Patents

1,3-oxazolidin-2-on-derivat och foerfaranden foer framstaellning daerav

Info

Publication number
SE463100B
SE463100B SE8502525A SE8502525A SE463100B SE 463100 B SE463100 B SE 463100B SE 8502525 A SE8502525 A SE 8502525A SE 8502525 A SE8502525 A SE 8502525A SE 463100 B SE463100 B SE 463100B
Authority
SE
Sweden
Prior art keywords
compound
oxazolidin
phenyl
piperidinopropyl
following formula
Prior art date
Application number
SE8502525A
Other languages
English (en)
Swedish (sv)
Other versions
SE8502525L (sv
SE8502525D0 (sv
Inventor
M Masaki
H Shinozaki
M Satoh
N Moritoh
K Hashimoto
T Kamishiro
Original Assignee
Nippon Chemiphar Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Chemiphar Co filed Critical Nippon Chemiphar Co
Publication of SE8502525D0 publication Critical patent/SE8502525D0/xx
Publication of SE8502525L publication Critical patent/SE8502525L/xx
Publication of SE463100B publication Critical patent/SE463100B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE8502525A 1984-09-28 1985-05-22 1,3-oxazolidin-2-on-derivat och foerfaranden foer framstaellning daerav SE463100B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59203624A JPS6183170A (ja) 1984-09-28 1984-09-28 新規な１，３−オキサゾリジン−２−オン誘導体およびその製造法

Publications (3)

Publication Number Publication Date
SE8502525D0 SE8502525D0 (sv) 1985-05-22
SE8502525L SE8502525L (sv) 1986-03-29
SE463100B true SE463100B (sv) 1990-10-08

Family

ID=16477122

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8502525A SE463100B (sv) 1984-09-28 1985-05-22 1,3-oxazolidin-2-on-derivat och foerfaranden foer framstaellning daerav

Country Status (27)

Country Link
US (1) US4644063A (nl)
JP (1) JPS6183170A (nl)
KR (1) KR900004323B1 (nl)
AR (1) AR240924A1 (nl)
AT (1) AT392069B (nl)
AU (1) AU566419B2 (nl)
BR (1) BR8502707A (nl)
CA (1) CA1252092A (nl)
CH (1) CH663207A5 (nl)
CS (1) CS273606B2 (nl)
DE (1) DE3519261C2 (nl)
DK (1) DK165952C (nl)
ES (2) ES8800571A1 (nl)
FR (1) FR2571052B1 (nl)
GB (2) GB8512975D0 (nl)
HU (1) HU199132B (nl)
IN (1) IN162060B (nl)
IT (1) IT1208807B (nl)
MX (2) MX161397A (nl)
MY (1) MY102081A (nl)
NL (1) NL193191C (nl)
NZ (1) NZ212143A (nl)
PH (1) PH20852A (nl)
RO (1) RO91422B (nl)
SE (1) SE463100B (nl)
SU (2) SU1402263A3 (nl)
ZA (1) ZA854001B (nl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6183147A (ja) * 1984-09-28 1986-04-26 Nippon Chemiphar Co Ltd 新規なアミノアルコール誘導体およびその製造法並びにそれを有効成分とするグルタミン酸遮断剤
JPH0759570B2 (ja) * 1986-05-06 1995-06-28 三井東圧化学株式会社 ２−オキサゾリジノン類の製造方法
JPH0713017B2 (ja) * 1986-06-18 1995-02-15 日本ケミファ株式会社 脳細胞保護作用を有する医薬組成物
EP0307141B1 (en) * 1987-09-10 1993-01-13 MERCK SHARP & DOHME LTD. Oxazoles and thiazoles for the treatment of senile dementia
CA1329128C (en) * 1988-03-24 1994-05-03 Nobuyoshi Iwata Isoxazolinones as cerebro-active drugs
JPH0314562A (ja) * 1988-04-11 1991-01-23 Nippon Chemiphar Co Ltd 新規なアルキレンジアミン誘導体およびグルタミン酸遮断剤
US5187171A (en) * 1989-01-09 1993-02-16 G. D. Searle & Co. Use of a glycine b partial agonist as an antipsychotic
DK0579169T3 (da) * 1992-07-14 1999-05-31 Nippon Chemiphar Co Alkylendiaminderivater
US5698573A (en) * 1993-09-15 1997-12-16 Merck, Sharp & Dohme, Ltd. Imidazolone and oxazolone derivatives as dopamine antagonists
DE4425613A1 (de) * 1994-07-20 1996-01-25 Bayer Ag 5-gliedrige Heteroaryl-oxazolidinone
US6037354A (en) * 1997-06-18 2000-03-14 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonists
ES2633269T3 (es) 2013-03-14 2017-09-20 Akzo Nobel Chemicals International B.V. Éter de celulosa como agente de control de dispersión y agente de resistencia a la lluvia

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2437389A (en) * 1948-03-09 Oxazoeidones and erocesstok
DE1135461B (de) * 1959-05-08 1962-08-30 Knoll Ag Verfahren zur Herstellung von basisch substituierten Phthalimidinen
FR1301267A (fr) * 1961-04-04 1962-08-17 Science Union Et Compagnie Soc Nouveaux dérivés de l'oxazolidinone-2 et leurs procédés de préparation
US3131197A (en) * 1963-03-13 1964-04-28 Smith Kline French Lab 5-(3, 4-carbonyldioxyphenyl)-3-isopropyl-2-oxazolidone
US3576808A (en) * 1967-09-15 1971-04-27 Miles Lab N-4-phenyl-1-piperazinylalkyl-5-phenyl-oxazolidinones
GB1222708A (en) * 1968-10-22 1971-02-17 Delalande Sa Novel 5-(n-substituted aminomethyl)-2-oxazolidinones and their process of preparation
FR2179582B1 (nl) * 1972-04-13 1975-10-10 Synthelabo

Also Published As

Publication number Publication date
CS392785A2 (en) 1990-08-14
NZ212143A (en) 1987-11-27
GB2165237A (en) 1986-04-09
MX161397A (es) 1990-09-20
FR2571052A1 (fr) 1986-04-04
US4644063A (en) 1987-02-17
SE8502525L (sv) 1986-03-29
MX21592A (es) 1994-01-31
DE3519261C2 (de) 1997-01-16
JPS6183170A (ja) 1986-04-26
AU4469785A (en) 1986-04-10
HUT39168A (en) 1986-08-28
FR2571052B1 (fr) 1988-03-04
NL193191B (nl) 1998-10-01
ES8800571A1 (es) 1987-11-01
DK230185A (da) 1986-03-29
RO91422A (ro) 1987-06-30
SU1431679A3 (ru) 1988-10-15
ES543517A0 (es) 1987-11-01
DK165952C (da) 1993-07-05
NL193191C (nl) 1999-02-02
ES8802152A1 (es) 1988-04-01
ZA854001B (en) 1986-01-29
CA1252092A (en) 1989-04-04
PH20852A (en) 1987-05-19
DK230185D0 (da) 1985-05-23
IT8567500A0 (it) 1985-05-30
HU199132B (en) 1990-01-29
DE3519261A1 (de) 1986-04-10
BR8502707A (pt) 1986-05-27
CH663207A5 (fr) 1987-11-30
GB8513685D0 (en) 1985-07-03
IN162060B (nl) 1988-03-19
ES557075A0 (es) 1988-04-01
GB8512975D0 (en) 1985-06-26
DK165952B (da) 1993-02-15
SU1402263A3 (ru) 1988-06-07
RO91422B (ro) 1987-07-02
AR240924A2 (es) 1991-03-27
SE8502525D0 (sv) 1985-05-22
AU566419B2 (en) 1987-10-22
CS273606B2 (en) 1991-03-12
AT392069B (de) 1991-01-25
KR900004323B1 (ko) 1990-06-22
KR860002502A (ko) 1986-04-26
GB2165237B (en) 1987-12-09
IT1208807B (it) 1989-07-10
JPH0469150B2 (nl) 1992-11-05
NL8501579A (nl) 1986-04-16
ATA165685A (de) 1990-07-15
MY102081A (en) 1992-03-31
AR240924A1 (es) 1991-03-27

Similar Documents

Publication Publication Date Title
JP2624901B2 (ja) ナフタレン構造を有する新しい誘導体、その製造方法及びそれを含む薬学的組成物
US4876284A (en) 1-alkyl-2-aminotetralin derivatives
US4721723A (en) Anti-depressant crystalline paroxetine hydrochloride hemihydrate
KR890000377B1 (ko) 아졸류의 제조방법
SE463100B (sv) 1,3-oxazolidin-2-on-derivat och foerfaranden foer framstaellning daerav
JPS6215546B2 (nl)
DK162992B (da) Analogifremgangsmaade til fremstilling af 1-piperazinyl-3-phenyl-indanderivater eller syreadditionssalte deraf
US5936091A (en) Processes and intermediates for resolving piperidyl acetamide stereoisomers
CZ284256B6 (cs) Nový způsob výroby formoterolu a příbuzných sloučenin
EP0030526B1 (en) New phenyl-azacycloalkanes, processes for preparation and pharmaceutical preparations for such compounds
NZ197582A (en) Dextrorotatory trans-4a,9b-5phenyl-2,3,4,4a,5,9b-hexahydro-1h-pyrido(4,3-b) indoles
EP0413667B1 (de) Halogenalkylphenyl-Alkohole, -Ketone und deren Hydrate
EP0411912B1 (en) Coumarin derivatives, their preparation and their use in the treatment of cerebrovascular disorders
KR910002671B1 (ko) 아미노-알콜 유도체의 제조방법
US4994617A (en) Aminoalcohols, their preparation process and their applications, particularly in therapeutics
FR2479815A1 (fr) Derives du cyclohexene
EP0230020B1 (en) 1,2,3,4,4a,9b-hexahydro-4a-aminoalkyldibenzofurans, a process for their preparation and their use as medicaments
US5286747A (en) 1-alkyl-2-aminotetralin derivatives
HU185432B (en) Process for producing indene derivatives
EP0724578A1 (en) Amine derivatives as calcium channel antagonists
JPH11505223A (ja) 光学的に純粋なベンゾフランカルボキシル酸誘導体を調製するための方法およびエフアロキサン調製のためのその用途
EP0520882B1 (fr) Dérivés de 2-aminopyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique
FR2702211A1 (fr) Nouveaux dérivés de la phénoxy-2 éthylamine, leur préparation et leur application en thérapeutique.
EP0091437A1 (en) Therapeutically useful tetralin derivatives iii, processes for preparation and pharmaceutical preparations for such compounds
JPH0550499B2 (nl)

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8502525-2

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8502525-2

Format of ref document f/p: F